NGF and peripheral neuropathy: Moreover, these meta-analyses reaffirmed the safety findings of the individual studies: anti-NGF antibodies increased peripheral neuropathy and sensitive adverse events (paresthesia, hypoesthesia), but there were no significant differences in serious adverse events compared with either placebo or NSAIDs [51].